Godavari Drugs Ltd Q1FY23 net profit declines to Rs. 92.15 lakhs

GODAVARI DRUGS LTD. has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 42.6168 crores during the period ended June 30, 2022 as compared to Rs. 44.3961 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 0.9215 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 1.2675 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 1.22 for the period ended June 30, 2022 as compared to Rs. 1.68 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 42.6168 crs	₹44.3961 crs	-4.01%
Net Profit	₹0.9215 crs	₹1.2675 crs	-27.30%
EPS	₹1.22	₹1.68	-27.38%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 42.6168 crores during the period ended June 30, 2022 as compared to Rs.44.4188 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.0.9215 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.1.4243 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.1.22 for the period ended June 30, 2022 as compared to Rs.1.89 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 42.6168 crs	₹44.4188 crs	-4.06%
Net Profit	₹0.9215 crs	₹1.4243 crs	-35.30%
EPS	₹1.22	₹1.89	-35.45%

Shares of GODAVARI DRUGS LTD. was last trading in BSE at Rs. 65.50 as compared to the previous close of Rs. 67.05. The total number of shares traded during the day was 7816 in over 71 trades.

The stock hit an intraday high of Rs. 68.70 and intraday low of 64.90. The net turnover during the day was Rs. 513312.00.

Source : Equity Bulls

Keywords

GodavariDrugs Q1FY23 ResultUpdate